Regulators, players and industry-convergence or divergence?
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: SANSOM, Lloyd (University of South Australia, Pharmacy and Medical Sciences, Adelaide, Australia)
In the past, the pharmaceutical industry considered that the registration of the product was the hurdle to market access(1). Over recent years this dynamic has changed with market access now being determined largely by the capacity to pay irrespective of registration status. Drug development was driven with the registration of the product as the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.